ALNY holders · CITADEL ADVISORS LLC 13F · ALNY stock
CITADEL ADVISORS LLC Alnylam Pharmaceuticals Inc (ALNY) 13F holding
CITADEL ADVISORS LLC reported 50,600 ALNY shares valued at $16.74B as of 2026-03-31 (COM), Call. Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 50,600 | $16.74B | Call |
| 2026-03-31 | 37,200 | $12.31B | Put |
| 2026-03-31 | 23,415 | $7.75B | COM |
| 2025-12-31 | 90,100 | $35.83B | Put |
| 2025-12-31 | 57,700 | $22.94B | Call |
| 2025-12-31 | 36,729 | $14.61B | COM |
| 2025-12-31 | 1,730 | $687.9M | COM |
| 2025-09-30 | 188,198 | $85.82B | COM |
| 2025-09-30 | 70,800 | $32.28B | Put |
| 2025-09-30 | 48,400 | $22.07B | Call |
| 2025-09-30 | 33,645 | $15.34B | COM |
| 2025-06-30 | 601,199 | $196.04B | COM |
| 2025-06-30 | 60,300 | $19.66B | Call |
| 2025-06-30 | 39,300 | $12.82B | Put |
Not investment advice. Cached 13F row, not EDGAR XML.